Wainwright Sees TG Therapeutics As Take-Out Target

By: via Benzinga
TG Therapeutics Inc's (NASDAQ: TGTX) increasingly attractive drug development pipeline could make it an acquisition target, an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.